Using hyperspectral imaging to assess endothelial dysfunction in preeclampsia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the use of hyperspectral imaging as a diagnostic and prognostic tool for preeclampsia, a pregnancy-related hypertensive disorder. It aims to evaluate the changes in endothelial and vascular function associated with preeclampsia, which can lead to severe complications for both mother and fetus. The study will involve women with singleton pregnancies who are at least 18 years old and able to provide informed consent. By utilizing non-invasive hyperspectral imaging, the researchers hope to identify microcirculatory disturbances that may persist postpartum and contribute to long-term cardiovascular risks.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* singleton pregnancies
* Age ≥ 18 years
* Patient's ability to provide consent
* written informed consent

Exclusion Criteria:

* Lack of consent
* Language barrier
* Dark to very dark skin type
* Severe fetal chromosomal/genetic/structural anomalies
* Laboratory changes in LDH, creatinine, or platelets due to other causes (e.g., isolated thrombocytopenia, e.g., immune thrombocytopenia, carcinoma)

Where it's running

• Heidelberg University Hospital, Department of Gynecology and Obstetrics
  Heidelberg, Germany Recruiting

Study contacts

• Principal investigator: Dr. med. Alexandra von Au — University Heidelberg
• Study coordinator: Dr. med. Anna Scholz
• Email: anna.scholz@med.uni-heidelberg.de
• Phone: +49 6221 56 32080

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Preeclampsia and normal pregnancy: retinal microcirculation using OCTA

  This study tests retinal blood flow in pregnant people with preeclampsia compared to healthy pregnant people using OCTA imaging.

  Recruiting Muğla Sıtkı Koçman University · Muğla, Menteşe · NCT07874191

• Endothelial Biomarkers in Pregnancy: Endothelial Extracellular Vesicles and Hypertensive Disorders

  This study tests whether endothelial extracellular vesicles in the blood differ between normotensive pregnant women and those with hypertensive disorders of pregnancy.

  Recruiting Josip Juraj Strossmayer University of Osijek · Osijek · NCT07728656

• Enhanced support for Connected MOM Plus in pregnancy and postpartum care

  A program that tests whether extra coaching helps pregnant people use Connected MOM Plus more, especially if they have limited access to care.

  Recruiting Tulane University · New Orleans, Louisiana · NCT07691541

• Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes

  This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.

  Recruiting University of Tennessee Graduate School of Medicine · Knoxville, Tennessee · NCT07565727

• Origins, features, and effects of preeclampsia on mother and baby

  This project will follow pregnant women diagnosed with preeclampsia through late pregnancy, delivery, and early postpartum to collect clinical data and biological samples to see how preeclampsia affects mothers and their babies.

  Recruiting Medical University of Graz · Graz · NCT07513558

• National first-trimester screening program to prevent preeclampsia in Denmark

  This program will try a new first-trimester screening for pregnant women with a single pregnancy in Denmark to find those at high risk of preeclampsia and offer early prevention such as low-dose aspirin.

  Recruiting at 3 sites Copenhagen University Hospital at Herlev · Aarhus and 2 other locations · NCT07485140

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.